Actinium Pharmaceuticals Announces Inducement Grants to New Employees
Actinium Pharmaceuticals granted inducement equity awards to newly appointed CFO Matt David, M.D., and SVP Business Development Sean Maenpaa. Dr. David received options on 250,000 shares at $0.97 plus up to 575,000 RSUs, while Mr. Maenpaa received options on 40,000 shares at $1.06 plus 120,000 RSUs, all granted under the 2026 Employment Inducement Award Plan outside the 2019 Stock Plan.
Key figures
- Cfo rsu base
- 250000
- Cfo milestone rsu
- 75000
- Cfo option shares
- 250000
- Cfo option strike
- $0.97
- Svp milestone rsu
- 50000
- Svp option shares
- 40000
- Svp option strike
- $1.06
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.